Top 5 Undervalued Stocks To Watch Right Now

The markets are far from efficient right now, with several undervalued stocks that boast historically-stable cash flows, scandal-free operations, and a robust profitability profile, relegated to the background. Most of the column inches and headlines are reserved for hyper-growth stocks and exciting recovery plays.

Post-pandemic, the outlook for several exceptional stocks remains pessimistic because of unforeseen losses and difficulties, offering investors access an attractive entry point previously unavailable available during their best years.

Today’s most prolific traders and investors have repeatedly shown that a well-informed value investing trading strategy can result in a very profitable career. Long-term and income investors covet undervalued stocks that gives them access to stable fundamentals, growth prospects and a steady income.

The following seven companies are excellent examples of mature enterprises trading at a discount:

Delta Air Lines (NYSE:DAL) BP (NYSE:BP) ConocoPhillips (NYSE:COP) Kellogg Co. (NYSE:K) Advanced Micro Devices (NASDAQ:AMD) American Express Company (NYSE:AXP) The Boeing Company (NYSE:BA)

Undervalued Stocks to Watch: Delta Air Lines (DAL) Source: EQRoy /

By several accounts, Delta Air Lines is one of the largest U.S. carriers. Due to its premium offerings, credit card partnerships, and impressive cost-cutting measures, the legacy carrier survived one of the toughest times in its history last year, albeit with some help from billions of dollars in government stimulus money.

Top 5 Undervalued Stocks To Watch Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN, a pre-clinical development for the treatment of refractory anemia; and ALN-TMP, a pre-clinical development for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia. The company?s partner-based programs comprise ALN-RSV01, a Phase II clinical trial program for the treatment of respiratory syncytial virus infection; ALN-VSP, a Phase I clinical trial completed program for the treatment of liver cancers; and ALN-HTT, a pre-clinical development for the treatment of Huntington?s disease. It has strategic alliances with Novartis Pharma AG; F. Hoffmann-La Roche Ltd; Takeda Pharmaceutical Company Limited; Isis Pharmaceuticals, Inc.; Medtronic Inc.; Kyowa Hakko Kirin Co., Ltd.; and Cubist Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Advisors’ Opinion:

  • [By ]

    Advisors Asset Management Inc. cut its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) by 25.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,685 shares of the biopharmaceutical company’s stock after selling 1,232 shares during the quarter. Advisors Asset Management Inc.’s holdings in Alnylam Pharmaceuticals were worth $625,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Alnylam Pharmaceuticals (ALNY)

    For more information about research offerings from Zacks Investment Research, visit

  • [By Cory Renauer]

    Staying on top of every new drugmaker takes a lot more time than you probably have. That said, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Pfizer (NYSE:PFE) shareholders want to keep their eyes on young Eidos and its lead candidate. Here’s why.

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) updated investors last month on how the launch of Onpattro, its first drug that was approved to treat transthyretin-mediated amyloidosis (ATTR), was going at the J.P. Morgan Healthcare Conference.

Top 5 Undervalued Stocks To Watch Right Now: Terrapin 3 Acquisition Corporation(TRTL)

Terrapin 3 Acquisition Corporation, incorporated on December 27, 2013, is a shell company. The Company is focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

The Company is not engaged in any operations. The Company has not generated any revenues.

Advisors’ Opinion:

  • [By Logan Wallace]

    TurtleCoin (CURRENCY:TRTL) traded 8% lower against the U.S. dollar during the one day period ending at 16:00 PM E.T. on February 6th. One TurtleCoin coin can now be bought for $0.0001 or 0.00000003 BTC on cryptocurrency exchanges including Trade Satoshi and TradeOgre. TurtleCoin has a total market cap of $3.57 million and $144,484.00 worth of TurtleCoin was traded on exchanges in the last day. Over the last week, TurtleCoin has traded down 19.7% against the U.S. dollar.

  • [By Max Byerly]

    Turtlecoin (CURRENCY:TRTL) traded up 6.5% against the dollar during the 24 hour period ending at 23:00 PM E.T. on August 14th. Turtlecoin has a market cap of $671,714.00 and $3,950.00 worth of Turtlecoin was traded on exchanges in the last day. During the last seven days, Turtlecoin has traded down 18.3% against the dollar. One Turtlecoin coin can now be bought for about $0.0000 or 0.00000001 BTC on exchanges including Trade Satoshi and TradeOgre.

Top 5 Undervalued Stocks To Watch Right Now: Take-Two Interactive Software, Inc.(TTWO)

Take-Two Interactive Software, Inc. develops, publishes, and markets interactive entertainment for consumers worldwide. The company offers its products under the Rockstar Games and 2K labels. It develops and publishes action/adventure products under the Grand Theft Auto, Max Payne, Midnight Club, and Red Dead names through developing sequels; offering downloadable episodes, and content and currency; and releasing titles for smartphones and tablets. The company also develops brands in other genres, including the L.A. Noire, Bully, and Manhunt franchises. In addition, it publishes various entertainment properties across platforms and a range of genres, including shooter, action, role-playing, strategy, sports, and family/casual entertainment under the BioShock, Mafia, Sid Meier’s Civilization, and XCOM Enemy Unknown series, as well as Borderlands and Evolve franchises; and various sports simulation titles, including its flagship NBA 2K series, a basketball video game and the WWE 2K series. The company’s portfolio of brands also comprise Carnival Games, Rockstar Games Presents Table Tennis, Sid Meier’s Pirates!, Spec Ops, and Top Spin. Its products are designed for console gaming systems, such as Sony’s PlayStation 3 and PlayStation 4, and Microsoft’s Xbox 360 and Xbox One; handheld gaming systems; and personal computers comprising smartphones and tablets. The company delivers its products through physical retail, digital download, online platforms, and cloud streaming services. Take-Two Interactive Software, Inc. was founded in 1993 and is headquartered in New York, New York.

Leave a Reply

Your email address will not be published.